![]() |
|
mRNA-based therapeutics offer precise and individualized therapies and avoid manufacturing issues associated with recombinant proteins. Additionally, compared with current therapeutics, mRNA is faster, flexible, and more cost-effective to produce. Learn more about key objectives, considerations, and strategies in mRNA manufacturing.
|